APOE and neuroenergetics: An emerging paradigm in Alzheimer's disease

Andrew B. Wolf, Richard John Caselli, Eric M. Reiman, Jon Valla

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

APOE is the major known genetic risk factor for late-onset Alzheimer's disease. Though relationships between APOE-encoded apolipoprotein E and β-amyloid are increasingly well described, mounting evidence supports wide-ranging effects of APOE on the brain. Specifically, APOE appears to affect brain network activity and closely related neuroenergetic functions that might be involved in vulnerability to neurodegenerative pathophysiology. These effects highlight the salience of further investigation into the diverse influences of APOE. Therefore, this article reviews the interplay between APOE and neuroenergetics and proposes areas for further investigation. This research might lead to the identification of novel therapeutic targets for the treatment and/or prevention of Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)1007-1017
Number of pages11
JournalNeurobiology of Aging
Volume34
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Alzheimer Disease
Brain
Apolipoproteins E
Amyloid
Research
Therapeutics

Keywords

  • Alzheimer's disease
  • APOE
  • Apolipoprotein E
  • Biomarkers
  • Brain imaging
  • Cytochrome oxidase
  • Energy metabolism
  • FDG PET
  • FMRI
  • Mitochondria
  • Neurodegeneration
  • Neuroenergetics

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

APOE and neuroenergetics : An emerging paradigm in Alzheimer's disease. / Wolf, Andrew B.; Caselli, Richard John; Reiman, Eric M.; Valla, Jon.

In: Neurobiology of Aging, Vol. 34, No. 4, 04.2013, p. 1007-1017.

Research output: Contribution to journalArticle

Wolf, Andrew B. ; Caselli, Richard John ; Reiman, Eric M. ; Valla, Jon. / APOE and neuroenergetics : An emerging paradigm in Alzheimer's disease. In: Neurobiology of Aging. 2013 ; Vol. 34, No. 4. pp. 1007-1017.
@article{c038860e50724ece83b36c9576a82ba8,
title = "APOE and neuroenergetics: An emerging paradigm in Alzheimer's disease",
abstract = "APOE is the major known genetic risk factor for late-onset Alzheimer's disease. Though relationships between APOE-encoded apolipoprotein E and β-amyloid are increasingly well described, mounting evidence supports wide-ranging effects of APOE on the brain. Specifically, APOE appears to affect brain network activity and closely related neuroenergetic functions that might be involved in vulnerability to neurodegenerative pathophysiology. These effects highlight the salience of further investigation into the diverse influences of APOE. Therefore, this article reviews the interplay between APOE and neuroenergetics and proposes areas for further investigation. This research might lead to the identification of novel therapeutic targets for the treatment and/or prevention of Alzheimer's disease.",
keywords = "Alzheimer's disease, APOE, Apolipoprotein E, Biomarkers, Brain imaging, Cytochrome oxidase, Energy metabolism, FDG PET, FMRI, Mitochondria, Neurodegeneration, Neuroenergetics",
author = "Wolf, {Andrew B.} and Caselli, {Richard John} and Reiman, {Eric M.} and Jon Valla",
year = "2013",
month = "4",
doi = "10.1016/j.neurobiolaging.2012.10.011",
language = "English (US)",
volume = "34",
pages = "1007--1017",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - APOE and neuroenergetics

T2 - An emerging paradigm in Alzheimer's disease

AU - Wolf, Andrew B.

AU - Caselli, Richard John

AU - Reiman, Eric M.

AU - Valla, Jon

PY - 2013/4

Y1 - 2013/4

N2 - APOE is the major known genetic risk factor for late-onset Alzheimer's disease. Though relationships between APOE-encoded apolipoprotein E and β-amyloid are increasingly well described, mounting evidence supports wide-ranging effects of APOE on the brain. Specifically, APOE appears to affect brain network activity and closely related neuroenergetic functions that might be involved in vulnerability to neurodegenerative pathophysiology. These effects highlight the salience of further investigation into the diverse influences of APOE. Therefore, this article reviews the interplay between APOE and neuroenergetics and proposes areas for further investigation. This research might lead to the identification of novel therapeutic targets for the treatment and/or prevention of Alzheimer's disease.

AB - APOE is the major known genetic risk factor for late-onset Alzheimer's disease. Though relationships between APOE-encoded apolipoprotein E and β-amyloid are increasingly well described, mounting evidence supports wide-ranging effects of APOE on the brain. Specifically, APOE appears to affect brain network activity and closely related neuroenergetic functions that might be involved in vulnerability to neurodegenerative pathophysiology. These effects highlight the salience of further investigation into the diverse influences of APOE. Therefore, this article reviews the interplay between APOE and neuroenergetics and proposes areas for further investigation. This research might lead to the identification of novel therapeutic targets for the treatment and/or prevention of Alzheimer's disease.

KW - Alzheimer's disease

KW - APOE

KW - Apolipoprotein E

KW - Biomarkers

KW - Brain imaging

KW - Cytochrome oxidase

KW - Energy metabolism

KW - FDG PET

KW - FMRI

KW - Mitochondria

KW - Neurodegeneration

KW - Neuroenergetics

UR - http://www.scopus.com/inward/record.url?scp=84872359922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872359922&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2012.10.011

DO - 10.1016/j.neurobiolaging.2012.10.011

M3 - Article

C2 - 23159550

AN - SCOPUS:84872359922

VL - 34

SP - 1007

EP - 1017

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 4

ER -